Status:
UNKNOWN
Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study
Lead Sponsor:
University of Lagos, Nigeria
Conditions:
Corona Virus Infection
Stroke
Eligibility:
All Genders
18-120 years
Phase:
NA
Brief Summary
Background: Coronavirus (CoViD-19) positive stroke survivors (SSv) with comorbidities faces possibility for mortality. Study reports success of physiotherapy in CoViD-19 positive SSv with multiple com...
Detailed Description
Introduction Coronavirus disease 2019 (CoViD-19) is a new pathogen that is highly contagious, can spread quickly, and it is capable of causing enormous health, economic and societal impacts in any set...
Eligibility Criteria
Inclusion
- Stroke survivors with COVID19
- Non-stroke individuals with COVID19
Exclusion
- Stroke survivors still in inpatient hospital care
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04471831
Start Date
July 13 2020
End Date
December 31 2021
Last Update
July 15 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.